Dr Heather Rogers
Heather D. Rogers is a board certified dermatologist and fellowship trained dermatologic surgeon, specialising in prevention and treatment of sun damaged skin including pre-skin cancers, skin cancers, moles and photo damage. However, in 2014, Dr Rogers founded Doctor Rogers Skin Solutions, which was the beginning of premium scientifically-proven, clean and allergen-free products.
Jennifer Yen
From Power Rangers to saving complexions with her skin care company purlisse beauty to momtrepreneur with her inspiration of the power of 8 Superfoods.
Jennifer Yen started her career as TV villainess on Power Rangers which wrecked her skin from the heavy makeup and bright lights inspiring her to create purlisse beauty: www.purlisse.com.
After becoming a mother and feeling completely depleted Yen quickly recovered through a Superfood lifestyle, used by generations of women in her family.
The power of Superfoods led Yen to start her second company, YENSA (meaning Color + Face in Chinese) the Superfood Cosmetic and the first Cosmetics meets Superfood Science brand, connecting Superfood Science, Complexion Cosmetics and Superfoods.
Each product is infused with 8 Superfoods (8 representing good luck, prosperity and infinite possibilities in Chinese culture).
Since launching on October 8, 2018 ,YENSA has received over 240,000 positive reviews with top features in CEW, PopSugar, WWD, Coveteur, Byrdie, Hollywood Reporter, Hollywood Life, Bustle, New Beauty and more. Cardi B and Jeffree Starr are among the influencer/celebrities to use the product + many more.
YENSA supports women organizations and recently partnered with Dress For Success #YourHourHerPower campaign featuring 8 SuperWomen: Michelle Phan, Jana Kramer, Aja White, Farnaz Charmatz, Sara Boyd, Deddeh Howard, Jesse Draper, Jennifer Yen who have shared their journeys in this campaign to help motivate and inspire women. Watch the full video here
Dr. Julie R. Bartholomew
Dr. Julie R. Bartholomew founded IMX Cosmetics, imxcosmetics.com, in Detroit in 2000. An accomplished social entrepreneur, award-winning inventor, panelist, keynote speaker and medical doctor; Dr. Bartholomew has been a named inventor on over 111 patent filings resulting in over 75 granted patents worldwide. She is one of an elite group of women representative of only 7.7% of female inventors in the United States. In 2001, Dr. Bartholomew pioneered and successfully executed the first beauty artificial intelligence (AI) formulation program for the customization of nail polish at point-of-sale. She developed an AI platform to navigate the micro-personalization of beauty, health and wellness products that can be made instantly in the retail space, online and/or at home.
Dr. Bartholomew and Bruce E. Teitelbaum co-founded RPG x IMX, rpximx.com, in 2017. Under this partnership, RPG x IMX leverages its intellectual property of more than 75 granted patents along with the founders’ long-established histories as innovators in the customization of cosmetics and consumer experiences. Their unique technology solutions dramatically re-focus shopping behavior to be tailored towards entirely personalized products and customized experiences. The transformative alliance of RPG x IMX offers real-time, in-store customization never before realized, turning passive consumers into active, highly engaged buyers.
Dr Stacie Calad-Thomson
Stacie Calad-Thomson is Chief Operating Officer of the Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium, a new public-private partnership that aims to accelerate the discovery of effective cancer therapies through integration of high-performance computing, diverse biological data, and emerging biotechnologies. Founding consortium members include the Department of Energy’s Lawrence Livermore National Laboratory, GSK, the National Cancer Institute’s Frederick National Laboratory for Cancer Research, and the University of California, San Francisco. The goal of the consortium is to create a new paradigm of drug discovery that would reduce the time from an identified drug target to clinical candidate from the current approximately six years to just 12 months. Stacie has worked for GSK, starting as a chemist and moving into business strategy and operations roles within R&D Platform Technology & Sciences, where she led several change initiatives. She has a BS (UC Berkeley) and a PhD (UC Irvine) in chemistry.
